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Germ-free rodents have no microorganisms living in or on them, allowing researchers
to specifically control an animal’s microbiota through the direct inoculation of bacteria of
interest. This strategy has been widely used to decipher host–microbe interactions as
well as the role of microorganisms in both (i) the development and function of the gut
barrier (mainly the intestinal epithelium) and (ii) homeostasis and its effects on human
health and disease. However, this in vivo model also offers a more realistic environment
than an assay tube in which to study microbe–microbe interactions, without most of
the confounding interactions present in the intestinal microbiota of conventionally raised
mice. This review highlights the usefulness of controlled-microbiota mice in studying
microbe–microbe interactions. To this end, we summarize current knowledge on germ-
free animals as an experimental model for the study of the ecology and metabolism of
intestinal bacteria as well as of microbe–microbe interactions.
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INTRODUCTION
Like human beings, conventional rodents harbor trillions of bacteria and viruses (Williams, 2014).
Germ-free (GF) animals, instead, are completely free of these microbes. In the field of gnotobiology
[from the Greek “gno¯tos” (known) and “biotic” (life)] (Gustafsson, 1959), such animals are used
to study the effects of inoculation with specific, known microbes. To raise GF mice, researchers
must separate pups from their mother’s wombs surgically, by aseptic cesarean or hysterectomy,
thus avoiding contact with microorganisms present in the mother’s vagina and skin. Alternatively,
GF pups can also be generated via the process of embryo transfer, which occurs in an isolator
environment and thus enables the implantation of cleansed embryos into GF recipients under
well-controlled conditions. A recipient female gives birth normally and cares for the offspring as
if they were her own pups, thus enhancing the pups’ survival rate. GF pups are kept in a sterile
environment their whole lives. In order to guarantee GF status, recurrent contamination tests are
performed on their feces. Once GF animals have been produced, it is possible to expand the colony
by crossing GF individuals. The new members of the colony have a natural birth and continue their
life under the same sterile conditions as their progenitors.
The accuracy of GF technology lies in the ability to control the composition of the environment
in which an organism develops and functions (Falk et al., 1998). To this end, gnotobiotic
facilities eliminate microbes present in food, water, and bedding through specific sterilization
protocols. Typically, these materials are heated to temperatures above 100◦C in order to kill
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bacteria and viruses. Possible contamination is prevented
through a fail-safe double-door system, in which autoclaved
supply cylinders are docked to a double-door port built
into the isolator wall. These security measures enable
inoculation by a single microorganism of interest, as well as the
consequent reproduction of mono-associated animals, known
as monoxenics. Animals inoculated with two microorganisms
are known as dixenics, those with three are trixenics, and so on
(Figure 1A) In the 1960s, Schaedler (Rockefeller University)
investigated the effects of different mixtures of bacteria in GF
mice. He was the first to study how a specific bacterium colonizes
the gut of initially GF mice (Schaedler et al., 1965a,b), and
his descriptions of what subsequently became known as the
“Schaedler flora” have served as important tools in standardizing
the microbiota of laboratory populations of rodents around the
world (Schaedler et al., 1965a,b). This microbiota has recently
been updated to include extremely oxygen-sensitive (EOS)
bacteria, which were not included in the first survey due to the
technical difficulties inherent in their isolation (Wymore Brand
et al., 2015). Nowadays, this altered Schaedler microbiota (ASF)
is used in several laboratories around the world for the study of
bacteria-host dynamics (Wymore Brand et al., 2015). In addition,
the ability to control the microbiota also enables the transfer of
a simplified or complete human microbiota to the GF animals
in order to create human-like conditions (Goodman et al.,
2011) (Figure 1B). However, if the transferred microbiota is not
completely defined, the resulting animals are not considered
gnotobiotic animals.
Typically, gnotobiotic animals are used to study the effects
of different members of the microbiota on the host. As is the
case with most biological research (Williams, 2014), the field of
gnotobiotics began with studies in which the system of interest—
in this case, the microbiota of various animals such as mice, rats,
guinea pigs, and chicks—was removed in order to examine its role
in different processes (Reyniers, 1959).
Studies with these animals have demonstrated that the
crosstalk between microbes and their host is essential for the
well-being of the host, and have indicated that the physiology
of healthy host individuals is dependent on the composition
of the gut microbiota. Indeed, changes in the gut microbiota
affect processes as varied as epithelial cell renewal, differentiation,
and architecture (Cherbuy et al., 2010); intestinal motility
(Falk et al., 1998); and host glycosylation patterns and gene
expression (Hooper et al., 2001). The study of gnotobiotic
rodents has also allowed researchers to identify and characterize
key microbes responsible for the development of the intestinal
immune system (Umesaki and Setoyama, 2000; Umesaki, 2014).
Thanks to gnotobiology, it is now widely recognized that the
microbiome serves its hosts in capacities that go far beyond its
role in food digestion. GF animals have dramatic alterations in
practically every phenotype that has been studied, including the
immune system, brain development, metabolism, behavior, and
the function of the heart, lungs, and lymph nodes (Williams,
2014). In addition, the combination of gnotobiotic techniques
with other new approaches has revealed causative associations
between alterations in the commensal microbiota and diseases
such as inflammatory bowel disease (IBD), obesity, and multiple
sclerosis, among others (Balish and Warner, 2002; Ley et al., 2006;
Turnbaugh et al., 2006; Berer et al., 2011).
WHY USE GNOTOBIOTIC RODENTS IN
STUDIES OF MICROBE–MICROBE
INTERACTIONS?
In the mammalian gut, microbes exist in a complex network
of cooperation and competition. Simplified experimental culture
conditions, in many cases, do not adequately represent the
in vivo activities and connections among different members of the
network, which prevents accurate evaluations of their individual
contributions to overall microbiota functionality (Stecher et al.,
2013a). Instead, gnotobiology offers a model in which microbe–
microbe interactions can be assessed directly in a more complex
environment. Furthermore, the use of initially GF animals
enables complete knowledge of the microbial composition of
a host, with consequent advantages for the interpretation of
results compared to studies of conventional mice. For all these
reasons, gnotobiotic studies offer a wide range of advantages
compared to both other animal models and in vitro conditions.
Gnotobiotics represents the optimal compromise between the
realistic complexity of conventional rodents and the controlled
nature of in vitro tests, without the incomplete knowledge and
control of the environment inherent in the former and the
oversimplifications of the latter.
Gnotobiotics as a Model of Synergistic
Microbial Interactions (Cooperative
Network Analysis)
The diverse intestinal microbiota is characterized by extensive
synergistic ecological interactions (Stecher et al., 2013a).
Gnotobiotic animals have been employed for deeper analyses of
these important microbial interactions, in particular (i) bacterial
succession, (ii) cross-feeding, and (iii) phage regulation of
bacterial populations.
Most studies of bacterial succession have focused on the
initial gut colonization process (primo-colonization; Fanaro
et al., 2003). In these studies, different bacteria are introduced
(sequentially or not) into GF animals in order to mimic the
progressive colonization of the sterile intestine that begins
immediately after birth. For instance, Tomas et al. (2013)
compared the transfer of two different microbiota to GF rats:
one from suckling rats, rich in early colonizing bacteria, and
the other obtained from adult rats, representative of a mature
microbiota. In rats with the early colonizing microbiota, strictly
anaerobic bacteria succeeded aero-tolerant bacteria. Because of
this coordinated process of bacterial succession, at the end of the
experiment the microbiotas of both groups had converged on the
same species profile, that of the mature inoculum. Similar results
have been described for the process of microbiota acquisition
in conventional mice (Gillilland et al., 2012). However, the
mechanisms behind this succession remain poorly described, as
this study focused only on host responses and not the evolution
in microbe–microbe interactions (Tomas et al., 2013).
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FIGURE 1 | Different models derived from germ-free (GF) mice. (A) Gnotobiotic models: GF mice can be colonized by one bacterium (microorganism A) in
order to obtain A-mono-associated mice. Similarly, GF mice can be colonized by microorganisms A and B to obtain A + B di-associated mice. When mice are
colonized by a basic microbiota such as the altered Schaedler Flora (ASF), we obtain mice with a simplified microbiota. (B) Non-gnotobiotic models: when mice are
colonized by human microbiota from healthy or unhealthy individuals (normally with dysbiosis), we obtain mice with human-associated microbiota (HMA).
Aero-tolerant bacteria are thought to “prepare” the colonic
environment for the growth of the strictly anaerobic bacteria
that will later predominate. Researchers have taken advantage
of this phenomenon to introduce certain strictly anaerobic
bacteria into mice with a controlled microbiota. For example,
the bacterium Faecalibacterium prausnitzii has well-known anti-
inflammatory properties that contribute to its role as a sensor
and promoter of intestinal health (Miquel et al., 2013, 2014).
However, because it is EOS, it is quite difficult to obtain
monoxenic F. prausnitzii-associated rodents. By preparing the
environment with Escherichia coli, though, Miquel et al. (2015)
were able to generate gnotobiotic mice that harbored both
F. prausnitzii and E. coli. Similarly, dixenic F. prausnitzii-
associated rats were also obtained by first inoculating the
rats with Bacteroides thetaiotaomicron (Wrzosek et al., 2013)
(Figure 2). B. thetaiotaomicron is an anaerobic bacterium; rather,
it decreases the oxido-reductive potential of the gastrointestinal
tract (GIT), thus enabling colonization by F. prausnitzii. In
addition, B. thetaiotaomicron and F. prausnitzii complement
each other metabolically: the former is acetate-producing
whereas the latter is acetate-consuming and butyrate-producing
(Duncan et al., 2002; Mahowald et al., 2009). In di-associated
rats, B. thetaiotaomicron produces acetate and F. prausnitzii
transforms this into butyrate (Wrzosek et al., 2013). These
short-chain fatty acids (SCFAs) are also able to stimulate the
host response. For instance, SCFA trigger pleiotropic signals
in the host, including signals regulating mucin synthesis and
secretion (Gaudier et al., 2004; Burger-van Paassen et al.,
2009). Both of these dixenic models illustrate the importance
of bacterial interactions during the colonization of GF rodents
by microorganisms. Since strictly anaerobic bacteria are major
components of the intestinal microbiota, these mutualistic
relationships are likely of vital importance in microbiota
acquisition and maintenance.
As mentioned above, the study of bacterial cross-feeding
phenomena is one area in which the tools of gnotobiology
will continue to be indispensable. Special models of human
microbiota have been developed for this purpose, as only 15% of
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FIGURE 2 | Bacteroides thetaiotaomicron (gray oval) and Faecalibacterium prausnitzii (black oval) di-associated mice production process. (A) When
B. thetaiotaomicron and F. prausnitzii were inoculated individually (gray arrows), only B. thetaiotaomicron colonized. (B) F. prausnitzii was successfully implanted after
week 4 following three weekly inoculations (black arrows). The oxido-reductive potential (measured by Eh value) in the cecum progressively decreased in the
presence of B. thetaiotaomicron (from 178 mV in GF rats to 141.1 mV at day 2) and decreased further in the presence of F. praustnizii (−274 mV at day 30).
Comparison of B. thetaiotaomicron mono-associated rats with dixenic rats revealed that in the presence of F. praustnizii there was a decrease in pH and acetate and
an increase in butyrate. Adapted from Wrzosek et al. (2013).
the bacterial species found in mice are also present in humans
(Tomas et al., 2012). Human microbiota-associated (HMA) mice
have also been employed as models in the study of the ecology
and metabolism of the human intestinal microbiota (Hirayama
and Itoh, 2005). For instance, studies of GF mice colonized
by human microbiota have clarified the cross-feeding activities
of Akkermansia muciniphila (Van den Abbeele et al., 2011), a
highly specialized bacterium capable of utilizing mucus as a sole
carbon and nitrogen source (Derrien et al., 2004; Everard et al.,
2013). The mucus-degrading ability of A. muciniphila and its
localization within the mucus layer have revealed its specific
niche and function within the gut (Swidsinski et al., 2009; Png
et al., 2010). By degrading mucus, A. muciniphila has the ability
to produce SCFAs (acetate and propionate) (Derrien et al., 2004),
which can stimulate microbiota interactions and a host response.
Specifically, oligosaccharides and acetate stimulate growth and
metabolic activity in commensal bacteria growing close to the
mucus layer, which may in turn discourage pathogenic bacteria
from crossing the mucus layer to reach the intestinal cells
(Derrien et al., 2004, 2010, 2011). Furthermore, an increase
in acetate and propionate due to the degradation of mucus
by A. muciniphila could stimulate other bacterial groups with
well-known butyrate-producing capacities as it has been proved
in vitro with other acetate producers (Rios-Covian et al., 2015).
Other scientific research on the human microbiome has
stimulated interest in probiotics, health-promoting agents that
are able to modulate the intestinal microbiota. In a recent
experiment, HFA mice were used to study the ability of
Bifidobacterium longum strain BB536 to modulate the gut
environment (Sugahara et al., 2015). HFA mice that were
supplemented with strain BB536 showed increased fecal levels
of butyrate and pimelate, a precursor of biotin. In addition, the
BB536-supplemented mice also had metabolic alterations related
to biotin synthesis, specifically involving Bacteroides caccae and
the increased prevalence of Eubacterium rectale, a butyrate
producer (Sugahara et al., 2015). All these possible interactions of
B. longum BB536 with the microbial community might explain, at
least in part, various reports of its beneficial physiological effects
on the host, including anti-allergy effects, competition against
harmful bacteria, and improvement in defecation frequency and
stool characteristics (Odamaki et al., 2007, 2012; Xiao et al., 2007;
Namba et al., 2010).
Gnotobiotics also offers clear advantages for the study of
phage-bacteria dynamics in the human gut. Bacterial viruses
(phages) are the most abundant biological group on earth
(Rodriguez-Valera et al., 2009). In some ecosystems, they are
capable of maintaining high levels of diversity of bacterial
strains through lysis of their hosts, in a process described by
the constant-diversity dynamics model of bacterial diversity;
this model is based on the fact that many of the genes that
differ between strains affect regions that are potential phage
recognition targets (Rodriguez-Valera et al., 2009). Recently,
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Reyes and coworkers introduced sequenced human gut bacteria
into GF mice and followed this with a controlled phage
attack using virus-like particles (VLPs) purified from the fecal
microbiota (Rodriguez-Valera et al., 2009).The authors observed
transient changes in bacterial community structure and bacterial
acquisition of resistance to phage attack through both ecological
and epigenetic mechanisms. These results illustrate the utility
of gnotobiotic mice in characterizing ecological relationships
among all components in the gut, viruses as well as bacteria.
Gnotobiotic Animals as Models of
Antagonistic Microbial Interactions
(Competitive Network Analysis)
Microbe–microbe interactions are not always cooperative.
Antagonistic cross-talk is a fundamental link in microbial ecology
and vital for the maintenance of host health. Gnotobiotic animals
have been employed to obtain deeper insight into the ability of
the microbiota to protect against infections, a process termed
colonization resistance (Stecher et al., 2013b).
Alterations in microbiota homeostasis generally result in
dysbiosis, an imbalance among bacterial species that often
occurs in the digestive tract. This condition, also known as
dysbacteriosis, is associated with illnesses such as IBD, chronic
obesity, cancer, and bacterial vaginosis (Martin et al., 2013,
2014a,b). Efforts to link these diseases to specific changes in the
microbiota have been hindered, though, by a lack of knowledge of
healthy bacterial communities. Indeed, it is not well understood
if dysbiosis itself is a consequence or a cause of an imbalance in
bacteria–bacteria relationships in the gastrointestinal tract.
When colonization resistance is disrupted through antibiotic-
mediated perturbations in the microbiota or other similar
phenomena, infections by nosocomial pathogens tend to increase
(Ubeda and Pamer, 2012; Stecher et al., 2013b). This observation
could be explained by the 1983 proposal of Freter et al. (1983a,b)
that populations of most intestinal bacteria are held in check
by competition for limited substrates. GF animals provide an
ideal testing ground in which to explore this hypothesis, as the
level of competition within a particular host can be manipulated
through the introduction of varying numbers of bacterial strains.
Studies using this approach have found that, because they lack
competing bacterial species, GF animals are more susceptible
than conventional ones to infections by E. coli, Clostridium
difficile, Vibrio cholerae, or Citrobacter rodentium (Collins and
Carter, 1978; Butterton et al., 1996; Stecher et al., 2005; Kamada
et al., 2012; Reeves et al., 2012). This hypothesis was further
supported by experiments in which the transplantation of
healthy fecal microbiota increased host resistance (Barman et al.,
2008; Endt et al., 2010; Lawley et al., 2012). Thus, Freter’s
theory provides a straightforward explanation of why gnotobiotic
mice are more sensitive to nosocomial infections: the lack of
substrate competition reduces barriers to colonization. However,
this conclusion is probably over-simplistic. Nowadays, studies
from various fields, including gnotobiology, have concluded that
colonization resistance is the result of not only a highly complex
interplay among members of the commensal microbiota, but also
of interactions among the microbiome [the entire community
of microbes and their genetic material; (Martin et al., 2014a),
the intestinal mucosa, and the immune system (Stecher et al.,
2013b)]. For example, GF mice have been used to examine how
individual bacteria species or bacterial communities influence
colonization resistance to C. difficile. In particular, GF mice that
had been inoculated only with a murine isolate from the family
Lachnospiraceae demonstrated partially restored colonization
resistance to C. difficile (Reeves et al., 2012), confirming that
the indigenous microbial community of the GIT and the inter-
relationships among its members determine susceptibility to
colonization and growth of C. difficile (Reeves et al., 2011, 2012).
These results highlight the potential of gnotobiotic mice as a
controlled environment in which to study antagonist microbial
interactions.
Colonization resistance is not the only example of antagonistic
interactions in the microbiota. For example, gnotobiotic models
have also been used to analyze growth competition between
the well-known yoghurt bacteria Streptococcus thermophilus
and Lactobacillus delbrueckii ssp. bulgaricus. The growth and
lactate production of these two bacteria were monitored in
different media and in the GIT of GF rats. When GF rats were
not supplemented with lactose, they were colonized only by
S. thermophilus, not by L. bulgaricus. However, when the rats’
drinking water was supplemented with lactose, both bacteria were
able to colonize. Interestingly, when lactose-supplemented GF
rats were inoculated with a mix of both bacteria, S. thermophilus
colonized the GIT faster and more extensively than L. bulgaricus
did. This work showed that S. thermophilus has a competitive and
growth advantage over L. bulgaricus in vitro as well as in vivo in
the GIT of GF rats (Ben-Yahia et al., 2012).
FUTURE TRENDS IN GNOTOBIOLOGY
At this point, gnotobiology is a mature science with applications
that go far beyond conventional ones. The classical experiments
and protocols used routinely in the study of microbes’
interactions with their hosts can easily be modified in order to
investigate interactions between and among multiple members
of the microbiota. As an example, a study aiming to understand
the effect of a microbe of interest on a particular disease
would benefit greatly from the use of mice with a controlled,
described microbiota. Such mice would then also be the perfect
experimental system in which to analyze the relationship of the
same microbe with the rest of the microbiota. Furthermore,
this analysis could be performed in both healthy and diseased
hosts. Similarly, our understanding of a pathogen’s activity
in a host could be enhanced through the use of various
monoxenic mice: such mice could be infected with a pathogen
and monitored in order to directly assess the effect of individual
resident microorganisms on the disease caused by the pathogen.
This model presents unique opportunities to analyze the
possible antagonistic interactions between resident and invading
microorganisms.
In brief, the options with gnotobiology are almost unlimited.
Furthermore, the combination of gnotobiotics with new-
omics approaches (e.g., transcriptomics, metabolomics, and
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genomics) and molecular genetics (genetically modified mice
and bacteria) could provide important insights into the roles of
microbe–microbe interactions. This knowledge could improve
our understanding of how commensal bacteria change into
opportunistic pathogens, how pathogens are able to proliferate,
and how probiotic bacteria could help to resolve dysbiosis.
CONCLUDING REMARKS
Here, we have summarized the most important outcomes
of gnotobiological research in the field of microbe–microbe
interactions as well as other concerns with relevance to the field.
The most significant questions in microbiota analysis, including
microbial interaction, rely on gnotobiotic animals for further
advancements in the field. GF animals will be indispensable in
future investigations of how certain microorganisms are able to
colonize and survive in the host, while others, e.g., pathogens,
are not. Studies of interaction and communication within the
microbiota will also depend heavily on gnotobiotic approaches.
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